Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 3,374 shares at $612.38 ($2.1M) on 2021-08-09, disclosed to the SEC on 2021-08-10.
Open-market sale of $2.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $612.38 | 1,687 | $1.0M | 50.0% |
| 2 | $612.38 | 1,687 | $1.0M | 50.0% |
| Total | $612.38 avg | 3,374 | $2.1M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |